New indication positions Repatha as an option for high-risk adults with elevated LDL cholesterol and no prior cardiovascular ...

Learn how Repatha can affect pregnancy, breastfeeding, and birth control.

Amgen (AMGN) announced that the U.S. FDA has broadened the approved use of Repatha to include adults at increased risk for ...

The Food and Drug Administration (FDA) has expanded the approval of Repatha ® (evolocumab) to include use in adults at increased risk for major adverse cardiovascular events (MACE) due to uncontrolled ...

The results are in on an eagerly anticipated trial of a new cholesterol-lowering medicine. Cardiologists are happy with the results.

The FDA has expanded approval of Amgen’s PCSK9 inhibitor Repatha (evolocumab), permitting use in adults at increased risk of major adverse cardiovascular events due to uncontrolled LDL cholesterol, ...

Most Medicare Part D and Advantage plans cover Repatha injections. Read about the cost of Repatha after paying the deductible, generic alternatives, and more.